Comparing Kisqali vs Tamoxifen

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Kisqali (ribociclib)	Tamoxifen	Enter another drug to compare

Kisqali (ribociclib)

Tamoxifen

Prescription only

Prescribed for Breast Cancer - Metastatic, Breast Cancer. Kisqali may also be used for purposes not listed in this medication guide.

Prescription only

Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Breast Cancer - Male, Breast Cancer - Palliative, Breast Cancer - Prevention, McCune-Albright Syndrome, Precocious... View more

More about Kisqali (ribociclib)

More about Tamoxifen

Ratings & Reviews

Kisqali has an average rating of 8.6 out of 10 from a total of 33 ratings on Drugs.com. 85% of reviewers reported a positive effect, while 3% reported a negative effect.

Tamoxifen has an average rating of 5.6 out of 10 from a total of 97 ratings on Drugs.com. 32% of reviewers reported a positive effect, while 29% reported a negative effect.

View all 33 reviews

View all 97 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

View all Kisqali side effects

Hot flashes (33.0%)
Insomnia (22.7%)
Fatigue (19.6%)
Joint pain (17.5%)
Mood swings (15.5%)
Depression (14.4%)
Pain (13.4%)

View all Tamoxifen side effects

Drug Class

CDK 4/6 inhibitors

Generic Availability

No lower cost generic approved

Lower cost generic

Pricing and Coupons * Prices are without insurance

Quantity	21 tablet
Strength	200 mg (200 mg daily-dose)
Per unit^*	$388.85
Cost^*	$8,165.91

View all Kisqali prices

Quantity	60 tablet
Strength	10 mg
Per unit^*	$1.09
Cost^*	$65.16

View all Tamoxifen prices

Get free Discount Card

Dosage Forms

Oral tablet

Oral tablet

Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

54.7 hours

231 hours

CSA Schedule ¹ View glossary of CSA terms

Not a controlled drug

Is not subject to the Controlled Substances Act.

Not a controlled drug

Is not subject to the Controlled Substances Act.

Pregnancy Category

Summary unavailable.

See the full pregnancy warnings document.

Category D Positive evidence of risk

See the full pregnancy warnings document.

Drug Interactions

A total of 740 drugs are known to interact with Kisqali:

313 major drug interactions (916 brand and generic names)
412 moderate drug interactions (1529 brand and generic names)
15 minor drug interactions (37 brand and generic names)

A total of 459 drugs are known to interact with Tamoxifen:

134 major drug interactions (499 brand and generic names)
310 moderate drug interactions (1018 brand and generic names)
15 minor drug interactions (42 brand and generic names)

Alcohol/Food/Lifestyle Interactions

Patients should not consume pomegranates, pomegranate juice, grapefruit, or grapefruit juice during... View more

Talk to your doctor before using tamoxifen with soy products. There is some evidence that... View more

Disease Interactions

First Approval Date

March 13, 2017

December 30, 1977

WADA Class View classifications

N/A

S4 - Hormone and Metabolic Modulators

More Information

Patient Resources

Kisqali uses

Tamoxifen uses

Professional Resources

Prescribing information

¹ The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Comparing Kisqali vs Tamoxifen

See also:

Trodelvy

Enhertu

Verzenio

Keytruda

Arimidex

Femara

Taxol

Xeloda

Herceptin

Ibrance

Further information

Comparing Kisqali vs Tamoxifen

See also:

Further information

Compare Drugs